FRI0709-HPR Levels of satisfaction with psoriatic arthritis (PSA) treatment and associated alignment between rheumatologists and their patients across latin america
Autor: | W. Bautista Molano, Steve Lobosco, V. F. Azevedo, Enrique R. Soriano, D. Rocio Gil, D. Vega Morales, I. alves pereira, J. A. Maldonado Cocco, L.M. Aldunate, F. Zazzetti, J.C. Cassola, Generoso Guerra |
---|---|
Rok vydání: | 2018 |
Předmět: |
musculoskeletal diseases
Moderate to severe Disease specific medicine.medical_specialty Latin Americans business.industry Patient demographics medicine.disease Treatment satisfaction Psoriatic arthritis Patient satisfaction Disease severity immune system diseases Internal medicine medicine skin and connective tissue diseases business |
Zdroj: | FRIDAY, 15 JUNE 2018. |
DOI: | 10.1136/annrheumdis-2018-eular.5597 |
Popis: | Objectives: To assess levels of rheumatologist and patient satisfaction with PsA treatment across Latin America and any disconnects that may exist between the two in real world clinical practice. Methods: Data from the 2015 PsA Disease Specific Programme (DSP), a cross-sectional, multi-national survey of patients and rheumatologists conducted in Argentina, Mexico, Colombia and Venezuela were analyzed. Rheumatologists (n=141) completed forms containing patient demographics, patient disease severity and treatment satisfaction. Patients self-reported their level of treatment satisfaction and disease severity. Results: A total of 293 PsA patients from across Latin America were included in this analysis. Current mean age was 49.9 years and 48.1% were female. Proportions of rheumatologists and patients reporting satisfaction with treatment were both similarly high (84% and 92% respectively), however current disease severity reporting differed more markedly between rheumatologists and patients (mild 78%/moderate-severe 22% rheumatologists vs. 63% mild/37% moderate-severe patients; p=0.002). When assessed for alignment, 19% of all rheumatologists and patients disagreed on the level of treatment satisfaction; 13% of this was due to rheumatologists stating greater dissatisfaction than their patients, with the remaining 6% due to patients stating greater dissatisfaction than their rheumatologists (p=0.0543). For current disease severity, 32% of all rheumatologists and patients disagreed; 25% due to patients stating greater severity than their rheumatologists, with 7% due to rheumatologists stating greater severity than their patients (p Conclusions: Despite many rheumatologists and their patients in Latin America reporting high levels of satisfaction with treatment, PsA patients can remain moderate to severe and disconnected from their physician. There is a need to improve physician/patient engagement as a means to improving clinical control. Disclosure of Interest: None declared |
Databáze: | OpenAIRE |
Externí odkaz: |